Oct 15, 2025 3:37 PM Eastern Daylight Time MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm Contacts The Schall Law FirmBrian Schall, Esq.www.schallfirm.comOffice: 310-301-3335info@schallfirm.com Share LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against MoonLake Immunotherapeutics ("MoonLake†or "the Company†) (NASDAQ: MLTX) for violations of ...